Charles River Laboratories International Inc. Stock Rises 7.1%, Outperforms Peers
Dow Jones2026/10/05 20:33This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Charles River Laboratories International Inc. advanced 7.1% to $310.77 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.7% to 7,773.95 and the Dow Jones Industrial Average rising 0.2% to 51,267.90. This was the stock's second consecutive day of gains. Charles River Laboratories International Inc. hit a new 52-week high, surpassing its previous peak of $303.31, which the company reached on August 27th. The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 0.1% to $308.65, Alnylam Pharmaceuticals Inc. rose 0.1% to $219.89, and Bio-Techne Corp. rose 0.25% to $72.58. Trading volume totaled 1.3 million, compared to the 50-day average of 936,013. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 05, 2026 16:33 ET (20:33 GMT)
This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. advanced 7.1% to $310.77 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.7% to 7,773.95 and the Dow Jones Industrial Average rising 0.2% to 51,267.90.
This was the stock's second consecutive day of gains.
Charles River Laboratories International Inc. hit a new 52-week high, surpassing its previous peak of $303.31, which the company reached on August 27th.
The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 0.1% to $308.65, Alnylam Pharmaceuticals Inc. rose 0.1% to $219.89, and Bio-Techne Corp. rose 0.25% to $72.58.
Trading volume totaled 1.3 million, compared to the 50-day average of 936,013.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 05, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Rumor: Tesla (TSLA.US) and SpaceX (SPCX.US) plan Terafab monthly production of one million wafers, feasibility questioned
According to reports, Tesla (TSLA.US) and SpaceX (SPCX.US) plan to achieve a production capacity of 1 million semiconductor wafers per month at the proposed Terafab factory starting in 2032.
Eurozone Sentix Investor Confidence Index slips to 2.4 in November from 2.7 in October
SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
Crypto prices
More
